Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults

BACKGROUND: This phase III clinical trial compared the immunogenicity and safety of a purified chick-embryo cell rabies vaccine (PCECV) administered according to a shortened post-exposure prophylaxis (PEP) 4-site/1-week intradermal regimen, compared with the currently recommended 2-site/Thai Red Cro...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerdpanich, Phirangkul, Chanthavanich, Pornthep, De Los Reyes, Mari Rose, Lim, Jodor, Yu, Delia, Ama, Ma. Cecilia, Mojares, Zenaida, Casula, Daniela, Arora, Ashwani Kumar, Pellegrini, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005579/
https://www.ncbi.nlm.nih.gov/pubmed/29874228
http://dx.doi.org/10.1371/journal.pntd.0006340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005579/
https://www.ncbi.nlm.nih.gov/pubmed/29874228
http://dx.doi.org/10.1371/journal.pntd.0006340

Ejemplares similares